Skip to main content
. 2005 Jul 21;9(5):R490–R497. doi: 10.1186/cc3774

Table 2.

Outcome and adverse events

Characteristic rhAPC group (n = 12) Control group (n = 12) p value
28-day survivors, n 10 9 1.00
Length of ICU stay, days 15 ± 14 20 ± 15 0.41
Length of hospital stay, days, 35 ± 20 46 ± 41 0.38
Patients discharged home (%) 5 (41.7) 5 (41.7) 1.00
At least one adverse event, n 9 7 0.41
Serious bleeding event, n 1 0 0.33

Data represent mean ± SD.